IO-202,Venetoclax
Immune-Onc Therapeutics,Roche,Abbvie
['leukemia', 'myeloid']
our dr. courtney dinardo presented a study at #eha23 evaluating a new therapy, io-202, for acute myeloid leukemia. hear her insights on fda fast track designation for io-202 and strategies for improving diversity in clinical trials. #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789